|Articles|April 1, 2013
Anti-VEGF therapy for the treatment of glaucoma
Early reports on off-label uses for anti-VEGFs are promising
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement












































